{
    "text": "In conclusion, anti-p16a IgG may be suitable for use as a prognostic biomarker for NSCLC.", 
    "denotations": [
        {
            "id": "T1", 
            "obj": "anti-p16a", 
            "span": {
                "begin": 15, 
                "end": 24
            }
        }, 
        {
            "id": "T1", 
            "obj": "NSCLC", 
            "span": {
                "begin": 83, 
                "end": 88
            }
        }
    ],
    "relations": [
        {
            "id":"R1",
            "pred":"causes",
            "subj":"T2", 
          "obj":"T1"}
    ]
}